Publications (85) María Remedios Alemán Valls publications

filter_list

2026

  1. Baseline resistance mutations and virological response to dolutegravir in treatment-naïve patients: a multicentre NGS study

    The Journal of antimicrobial chemotherapy, Vol. 81, Núm. 4

  2. Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007–2023)

    Open Forum Infectious Diseases, Vol. 13, Núm. 6, pp. 01-11

  3. Diagnosis of HIV infection during pregnancy: Trends from a national cohort in Spain

    HIV Medicine, Vol. 27, Núm. 2, pp. 270-282

  4. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

    Journal of the International AIDS Society, Vol. 29, Núm. 4

  5. Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort

    HIV Medicine, Vol. 27, Núm. 4, pp. 546-559

  6. Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort

    AIDS (London, England), Vol. 40, Núm. 4, pp. 414-427

  7. Hodgkin and non-Hodgkin lymphomas in the post-antiretroviral therapy era according to HIV virological suppression

    HIV Medicine

2025

  1. A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

    Journal of Antimicrobial Chemotherapy, Vol. 80, Núm. 12, pp. 3438-3451

  2. Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?

    Epidemiology and Infection, Vol. 153

  3. Changes in Body Mass Index in Children and Adolescents Living with Human Immunodeficiency Virus in Europe and Thailand Starting Dolutegravir

    Open Forum Infectious Diseases, Vol. 12, Núm. 12

  4. Health-related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short-term changes over time

    HIV Medicine, Vol. 26, Núm. 4, pp. 606-620

  5. Increased mortality and morbidity risk in people with early HIV care interruption in Spain

    AIDS, Vol. 39, Núm. 9, pp. 1224-1234

  6. Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 43, Núm. 10, pp. 645-651

  7. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine, Vol. 26, Núm. 2, pp. 308-318

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 1

  3. Rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV

    Emerging Microbes and Infections, Vol. 13, Núm. 1

2023

  1. Dermoscopy of monkeypox: Histopathology and clinical correlation

    Journal of the European Academy of Dermatology and Venereology

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836